Quaking, an RNA-binding protein, is a critical regulator of vascular smooth muscle cell phenotype

Circulation Research

Volumn 113, Issue 9, 2013, Pages 1065-1075

  Van Der Veer, Eric P ^a,b   De Bruin, Ruben G ^a,b   Kraaijeveld, Adriaan O ^c   De Vries, Margreet R ^a,c   Bot, Ilze ^c,d   Pera, Tonio ^c   Segers, Filip M ^d,i   Trompet, Stella ^a,c   Van Gils, Janine M ^a,b   Roeten, Marko K ^a,b   Beckers, Cora M ^a,i   Van Santbrink, Peter J ^d   Janssen, Anique ⁱ   Van Solingen, Coen ^a,b   Swildens, Jim ^c   De Boer, Hetty C ^a,b   Peters, Erna A ^a,c   Bijkerk, Roel ^a,b   Rousch, Mat ⁱ   Doop, Merijn ^d   Kuiper, Johan ^d   Schalij, Martin Jan ^c   Van Der Wal, Allard C ^e   Richard, Stéphane ^f   Van Berkel, Theo J C ^d   Geoffrey Pickering, J ^g   Hiemstra, Pieter S ^c   Goumans, Marie Jose ^b   Rabelink, Ton J ^a,b   De Vries, Antoine A F ^c   Quax, Paul H A ^a,c   Wouter Jukema, J ^a,c,h   Biessen, Erik A L ^d,i   Van Zonneveld, Anton Jan ^a,b   more..

^a Einthoven Laboratory of Experimental Vascular Medicine   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Department of Cardiology ^*  (United States)

^d LEIDEN UNIVERSITY   (Netherlands)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

^f MCGILL UNIVERSITY   (Canada)

^g ROBARTS RESEARCH INSTITUTE   (Canada)

^h ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

ⁱ MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Alternative splicing; Differentiation; Myocardin; Qk; Restenosis; RNA binding protein Quaking; Vascular injury; Vascular smooth muscle cells

Indexed keywords

CONTRACTILE PROTEIN; MESSENGER RNA; MESSENGER RNA PRECURSOR; MYOCARDIN; QUAKING PROTEIN; RNA BINDING PROTEIN; UNCLASSIFIED DRUG; NUCLEAR PROTEIN; QK PROTEIN, MOUSE; QKI PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

ALTERNATIVE RNA SPLICING; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL INJURY; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; EXON; FEMALE; GENE EXPRESSION; GENE MUTATION; MOUSE; NEOINTIMA; NERVE CELL PLASTICITY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; QUAKING MOUSE; RESTENOSIS; RNA LOCALIZATION; RNA PROCESSING; RNA SPLICING; RNA STABILITY; SMOOTH MUSCLE FIBER; SPLICEOSOME; VASCULAR SMOOTH MUSCLE; VASCULARIZATION; ANIMAL; C57BL MOUSE; CAROTID ARTERY INJURY; CELL MOTION; COMMON CAROTID ARTERY; CORONARY BLOOD VESSEL; DISEASE MODEL; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HEK293 CELL LINE; HUMAN; HYPERPLASIA; METABOLISM; PATHOLOGY; RNA INTERFERENCE;

ALTERNATIVE SPLICING; ANIMALS; CAROTID ARTERY INJURIES; CAROTID ARTERY, COMMON; CELL MOVEMENT; CELL PROLIFERATION; CORONARY RESTENOSIS; CORONARY VESSELS; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMANS; HYPERPLASIA; MICE; MICE, INBRED C57BL; MICE, QUAKING; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NEOINTIMA; NUCLEAR PROTEINS; PHENOTYPE; RNA INTERFERENCE; RNA-BINDING PROTEINS; TRANS-ACTIVATORS; TRANSFECTION;

EID: 84886095882     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.113.301302     Document Type: Article

References (44)

1. Apponi LH, Corbett AH, Pavlath GK. RNA-binding proteins and gene regulation in myogenesis. Trends Pharmacol Sci. 2011;32:652-658.
2. Chénard CA, Richard S. New implications for the QUAKING RNA binding protein in human disease. J Neurosci Res. 2008;86:233-242. (Pubitemid 351196729)
3. Vernet C, Artzt K. STAR, a gene family involved in signal transduction and activation of RNA. Trends Genet. 1997;13:479-484. (Pubitemid 28004921)
4. Bockbrader K, Feng Y. Essential function, sophisticated regulation and pathological impact of the selective RNA-binding protein QKI in CNS myelin development. Future Neurol. 2008;3:655-668.
5. Ryder SP, Williamson JR. Specificity of the STAR/GSG domain protein Qk1: implications for the regulation of myelination. RNA. 2004;10:1449-1458. (Pubitemid 39122115)
6. Galarneau A, Richard S. Target RNA motif and target mRNAs of the Quaking STAR protein. Nat Struct Mol Biol. 2005;12:691-698. (Pubitemid 43086275)
7. Bohnsack BL, Lai L, Northrop JL, Justice MJ, Hirschi KK. Visceral endoderm function is regulated by quaking and required for vascular development. Genesis. 2006;44:93-104.
8. Li Z, Takakura N, Oike Y, Imanaka T, Araki K, Suda T, Kaname T, Kondo T, Abe K, Yamamura K. Defective smooth muscle development in qkIdeficient mice. Dev Growth Differ. 2003;45:449-462. (Pubitemid 38067911)
9. Noveroske JK, Lai L, Gaussin V, Northrop JL, Nakamura H, Hirschi KK, Justice MJ. Quaking is essential for blood vessel development. Genesis. 2002;32:218-230. (Pubitemid 34260453)
10. Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev. 2004;84:767-801. (Pubitemid 38823766)
11. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809. (Pubitemid 23132154)
12. Agema WR, Jukema JW, Pimstone SN, Kastelein JJ. Genetic aspects of restenosis after percutaneous coronary interventions: towards more tailored therapy. Eur Heart J. 2001;22:2058-2074. (Pubitemid 33091449)
13. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999;340:115-126.
14. Lee T, Roy-Chaudhury P. Advances and new frontiers in the pathophysiology of venous neointimal hyperplasia and dialysis access stenosis. Adv Chronic Kidney Dis. 2009;16:329-338.
15. Roy-Chaudhury P, Arend L, Zhang J, Krishnamoorthy M, Wang Y, Banerjee R, Samaha A, Munda R. Neointimal hyperplasia in early arteriovenous fistula failure. Am J Kidney Dis. 2007;50:782-790. (Pubitemid 47588553)
16. Mitchell RN, Libby P. Vascular remodeling in transplant vasculopathy. Circ Res. 2007;100:967-978. (Pubitemid 46598921)
17. Chen J, Kitchen CM, Streb JW, Miano JM. Myocardin: a component of a molecular switch for smooth muscle differentiation. J Mol Cell Cardiol. 2002;34:1345-1356. (Pubitemid 35244412)
18. Du KL, Ip HS, Li J, Chen M, Dandre F, Yu W, Lu MM, Owens GK, Parmacek MS. Myocardin is a critical serum response factor cofactor in the transcriptional program regulating smooth muscle cell differentiation. Mol Cell Biol. 2003;23:2425-2437. (Pubitemid 36351024)
19. Miano JM. Serum response factor: toggling between disparate programs of gene expression. J Mol Cell Cardiol. 2003;35:577-593. (Pubitemid 36681543)
20. Creemers EE, Sutherland LB, Oh J, Barbosa AC, Olson EN. Coactivation of MEF2 by the SAP domain proteins myocardin and MASTR. Mol Cell. 2006;23:83-96. (Pubitemid 43963447)
21. Li S, Sims S, Jiao Y, Chow LH, Pickering JG. Evidence from a novel human cell clone that adult vascular smooth muscle cells can convert reversibly between noncontractile and contractile phenotypes. Circ Res. 1999;85:338-348. (Pubitemid 29398866)
22. Owens GK. Regulation of differentiation of vascular smooth muscle cells. Physiol Rev. 1995;75:487-517.
23. Rittersma SZ, Meuwissen M, van der Loos CM, Koch KT, de Winter RJ, Piek JJ, van der Wal AC. Eosinophilic infiltration in restenotic tissue following coronary stent implantation. Atherosclerosis. 2006; 184:157-162. (Pubitemid 41721083)
24. Pires NM, Pols TW, de Vries MR, van Tiel CM, Bonta PI, Vos M, Arkenbout EK, Pannekoek H, Jukema JW, Quax PH, de Vries CJ. Activation of nuclear receptor Nur77 by 6-mercaptopurine protects against neointima formation. Circulation. 2007;115:493-500. (Pubitemid 46184201)
25. Lardenoye JH, de Vries MR, Löwik CW, Xu Q, Dhore CR, Cleutjens JP, van Hinsbergh VW, van Bockel JH, Quax PH. Accelerated atherosclerosis and calcification in vein grafts: a study in APOE 3 Leiden transgenic mice. Circ Res. 2002;91:577-584.
26. Krohn R, Raffetseder U, Bot I, Zernecke A, Shagdarsuren E, Liehn EA, van Santbrink PJ, Nelson PJ, Biessen EA, Mertens PR, Weber C. Y-box binding protein-1 controls CC chemokine ligand-5 (CCL5) expression in smooth muscle cells and contributes to neointima formation in atherosclerosis-prone mice. Circulation. 2007;116:1812-1820. (Pubitemid 350287106)
27. Li S, Fan YS, Chow LH, Van Den Diepstraten C, van Der Veer E, Sims SM, Pickering JG. Innate diversity of adult human arterial smooth muscle cells: cloning of distinct subtypes from the internal thoracic artery. Circ Res. 2001;89:517-525. (Pubitemid 34132646)
28. Bot I, von der Thüsen JH, Donners MM, Lucas A, Fekkes ML, de Jager SC, Kuiper J, Daemen MJ, van Berkel TJ, Heeneman S, Biessen EA. Serine protease inhibitor Serp-1 strongly impairs atherosclerotic lesion formation and induces a stable plaque phenotype in ApoE-/-mice. Circ Res. 2003;93:464-471. (Pubitemid 37100012)
29. Hinz B, Celetta G, Tomasek JJ, Gabbiani G, Chaponnier C. Alpha-smooth muscle actin expression upregulates fibroblast contractile activity. Mol Biol Cell. 2001;12:2730-2741. (Pubitemid 33051938)
30. Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. Lab Invest. 1983;49:327-333. (Pubitemid 13012062)
31. Imamura M, Long X, Nanda V, Miano JM. Expression and functional activity of four myocardin isoforms. Gene. 2010;464:1-10.
32. Lusis AJ. Atherosclerosis. Nature. 2000;407:233-241.
33. Pullmann R Jr, Juhaszova M, López de Silanes I, Kawai T, Mazan-Mamczarz K, Halushka MK, Gorospe M. Enhanced proliferation of cultured human vascular smooth muscle cells linked to increased function of RNA-binding protein HuR. J Biol Chem. 2005;280:22819-22826. (Pubitemid 40853188)
34. Hafner M, Landthaler M, Burger L, Khorshid M, Hausser J, Berninger P, Rothballer A, Ascano M Jr, Jungkamp AC, Munschauer M, Ulrich A, Wardle GS, Dewell S, Zavolan M, Tuschl T. Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell. 2010;141:129-141.
35. Scheibe M, Butter F, Hafner M, Tuschl T, Mann M. Quantitative mass spectrometry and PAR-CLIP to identify RNA-protein interactions. Nucleic Acids Res. 2012;40:9897-9902.
36. Hall MP, Nagel RJ, Fagg WS, Shiue L, Cline MS, Perriman RJ, Donohue JP, Ares M Jr. Quaking and PTB control overlapping splicing regulatory networks during muscle cell differentiation. RNA. 2013;19:627-638.
37. Ilagan RM, Genheimer CW, Quinlan SF, Guthrie KI, Sangha N, Ramachandrannair S, Kelley RW, Presnell SC, Basu J, Ludlow JW. Smooth muscle phenotypic diversity is mediated through alterations in myocardin gene splicing. J Cell Physiol. 2011;226:2702-2711.
38. Wang Z, Wang DZ, Pipes GC, Olson EN. Myocardin is a master regulator of smooth muscle gene expression. Proc Natl Acad Sci U S A. 2003;100:7129-7134. (Pubitemid 36706404)
39. Firulli AB, Miano JM, Bi W, Johnson AD, Casscells W, Olson EN, Schwarz JJ. Myocyte enhancer binding factor-2 expression and activity in vascular smooth muscle cells. Association with the activated phenotype. Circ Res. 1996;78:196-204. (Pubitemid 26042838)
40. Kondo T, Furuta T, Mitsunaga K, Ebersole TA, Shichiri M, Wu J, Artzt K, Yamamura K, Abe K. Genomic organization and expression analysis of the mouse qkI locus. Mamm Genome. 1999;10:662-669. (Pubitemid 29393670)
41. Mesquita FS, Dyer SN, Heinrich DA, Bulun SE, Marsh EE, Nowak RA. Reactive oxygen species mediate mitogenic growth factor signaling pathways in human leiomyoma smooth muscle cells. Biol Reprod. 2010;82:341-351.
42. Blach O, Pollack AMa, Douglas D. Smooth muscle hyperplasia of the epididymis. J Surg Case Reports 2011;1-4.
43. Estrada CR, Adam RM, Eaton SH, Bägli DJ, Freeman MR. Inhibition of EGFR signaling abrogates smooth muscle proliferation resulting from sustained distension of the urinary bladder. Lab Invest. 2006;86: 1293-1302. (Pubitemid 44789918)
44. Wang J, Niu W, Nikiforov Y, Naito S, Chernausek S, Witte D, LeRoith D, Strauch A, Fagin JA. Targeted overexpression of IGF-I evokes distinct patterns of organ remodeling in smooth muscle cell tissue beds of transgenic mice. J Clin Invest. 1997;100:1425-1439. (Pubitemid 27425767)